About
Topicals & Suppositories
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (6)
Blair Gordon
Vice President, Research and Development
Edesa Biotech
executive
Blair Gordon
Vice President, Research and Development
Edesa Biotech
executive
Gary Koppenjan
Vice President, Corporate Affairs
Edesa Biotech
executive
Michael Brooks
President
Edesa Biotech
executive
Par Nijhawan
Chief Executive Officer
Edesa Biotech
executive
Peter J
Chief Financial Officer
Edesa Biotech
executive
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
2,055
By Phase
PHASE2: 5PHASE2/PHASE3: 1
By Status
RECRUITING: 4SUSPENDED: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06701682Collaborator
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
PHASE2Recruiting
200 participants
Started: Jun 21, 2025 · Completed: Feb 8, 2028
NCT06701669Collaborator
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
PHASE2Recruiting
200 participants
Started: Jun 10, 2025 · Completed: Feb 8, 2028
NCT06703073Collaborator
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
PHASE2Recruiting
600 participants
Started: Jun 10, 2025 · Completed: Feb 8, 2028
NCT06701656Collaborator
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
PHASE2Recruiting
200 participants
Started: Feb 26, 2025 · Completed: Feb 8, 2028
NCT04401475Lead Sponsor
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19
PHASE2/PHASE3Suspended
644 participants
Started: Nov 25, 2020 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Markham, ON, Canada
Map
Loading map...